Speakers
Default
Lukasz Beczkowski
COO
Pratia
AB
Arianna Bertolani
Head of Project Developmenr
Consorzio per Valutazioni Biologiche e Farmacologiche (CVBF)
Susan Bhatti
Director EU Global Regulatory and Scientific Policy
Merck BV
Jana Brajdih Cendak
Medical and Pharmacovigilance Lead
Billev Pharma East
DCD
Dagmar Chase, Dr.
GCP Consultant and Trainer
Clinrex Munich
Richard Davies
Vice President, Solution Expert
CluePoints
Martine Dehlinger-Kremer
VP SA and President
ICON plc and EUCROF
Aurélie Delaunay
Quality Strategy Lead
Merck Santé s.a.s.
Joanne Donald
Computerized Systems Process Portfolio Lead
Roche
Jakub Dvořáček
Deputy Minister of Health
Czech Republic
Roman Fishchuk
CEO, clinical trials unit. ENT doctor
Central city clinical hospital of Ivano-Frankivsk city council
Sally Hofmeister
Board Member/Duchenne Community Advisory Board Coordinator
World Duchenne Organisation
CH
Caitriona Holohan
DX CR UK Head of Clinical Testing
ALMAC Diagnostic Services Ltd
Eva Hrušková Reinová
Head of Clinical Trials of Pharmaceuticals Unit Clinical Trials of Medicinal Products Department
SUKL
Lenka Kaska
Corporate Affairs Director
Pfizer
Vincent Keunen
CEO & founder
Andaman7
Neil Konopka
Senior Director, Risk Management & Regulatory Compliance, Oracle Health Compliance Organization
Oracle
Stéphanie Kromar
Head of Regulatory Affairs
EORTC
Bart Lagerwaard
Assistant Professor
Trials at Home
Eleanor McLaurin
Solution Sales Specialist
Medidata, Dassault Systemes
Ute Metzger
Head of Quality Management
CeGaT GmbH
Oksana Nedostup
Freelancer Clinical Logistics Researcher
ULC
Martin O'Kane
Regional Head, Regulatory Affairs EU Policy & Liaison
Novartis
Pierre Omnes
Executive Director
TransPerfect
Doug Peddicord
Executive Director
ACRO
Laura Pioppo
ACT EU Programme manager
European Medicines Agency
Georg Schmidt
Professor of Cardiology
AKEK
Gabriele Schwarz
GCP Strategy Expert
Federal Institute for Drugs and Medical Devices (BfArM)
Sofie Sibia
Director of Development
IDTM
Rebecca Stanbrook
Executive Director, Regulatory and Development Policy, Regulatory Affairs
Novartis Pharma AG